Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
Jazz Pharmaceuticals (JAZZ) management will participate in fireside chats at three upcoming investor conferences in November and December 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Jazz Pharmaceuticals (JAZZ) management will participate in fireside chats at three upcoming investor conferences in November and December 2026.
The Jefferies London Global Healthcare Conference chat is November 17 at 8:00 a.m. ET. The Piper Sandler 38th Annual Healthcare Conference chat is December 2 at 8:00 a.m. ET, followed by Citi's 2026 Global Healthcare Conference at 3:00 p.m. ET. Audio webcasts will be available on the investor website, with replays archived for 30 days.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- Jefferies London Global Healthcare Conference on Tuesday, November 17, 2026, at 8:00 a.m. ET
- Piper Sandler 38th Annual Healthcare Conference on Wednesday, December 2, 2026, at 8:00 a.m. ET
- Citi's 2026 Global Healthcare Conference on Wednesday, December 2, 2026, at 3:00 p.m. ET
Audio webcasts of the fireside chats will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations. A replay of the webcasts will be archived on the website for 30 days.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with rare disease — often with limited or no therapeutic options. We have a diverse portfolio of medicines, including leading therapies addressing epilepsies, cancers and sleep disorders. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.
Contacts
Investors:
InvestorInfo@jazzpharma.com
Ireland +353 1 634 7800
U.S. +1 650 496 2717
Media:
CorporateAffairsMediaInfo@jazzpharma.com
Ireland +353 1 637 2141
U.S. +1 215 867 4948
View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-upcoming-investor-conferences-302928431.html
SOURCE Jazz Pharmaceuticals plc